mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.7 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |